Dapansutrile Clinical Trials

3 actively recruiting trials across 1 location

Also known as: 3-methanesulfonyl-propionitrile, OLT1177

Pipeline

Phase 2: 2Phase 2/3: 1

Top Sponsors

Olatec Therapeutics LLC1
Marc Donath1
Cambridge University Hospitals NHS Foundation Trust1

Indications

Gout Attack1
Acute Gout Flare1
Gout Flare1
Gouty Arthritis1
Gout1

Other2 trials

A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease

Phase 2

Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia

Phase 2

Birmingham, Alabama1 trial

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

University of Alabama at Birmingham

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.